Last reviewed · How we verify

NCT06655714

Evaluation of Inadequate Response to Ultrasound-Guided Subacromial Corticosteroid Injection in Shoulder Impingement Syndrome

Completed Last updated 29 January 2025
What this trial tests

trial testing No intervention in Impingement Syndrome in 72 participants. Completed in 15 December 2024.

Timeline
15 October 2024
Primary endpoint
15 December 2024
15 December 2024

Quick facts

Lead sponsorBeylikduzu State Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment72
Start date15 October 2024
Primary completion15 December 2024
Estimated completion15 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Beylikduzu State Hospital

Who can join

Adults 18 to 65, any sex, with Impingement Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the impact of central sensitization in patients with shoulder impingement syndrome who have shown an inadequate response to ultrasound-guided subacromial corticosteroid injection. Additionally, the patients' pain perception and emotional state will be evaluated, and the relationships between these factors and the treatment response will be analyzed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Impingement Syndrome

Currently open trials in the same condition.

Other Beylikduzu State Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06655714.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing